Oldfield Partners’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Oldfield Partners's PFE Position: Q3 2019 in Review
Oldfield Partners sold out of Pfizer (PFE) in Q3 2019, closing a stake of 51,277 shares — an estimated $2.11M sold.
Oldfield Partners first reported a position in PFE in Q2 2013 and held it in 25 quarters. The position peaked at $4.81M in Q3 2018. 2,323 funds tracked by Wall St. Rank hold PFE as of Q3 2019.
- Oldfield Partners reported no remaining Pfizer position as of Q3 2019 after selling out during the quarter.
- Oldfield Partners sold 51,277 Pfizer shares in Q3 2019, an estimated $2.11M.
- Oldfield Partners first reported a position in Pfizer in Q2 2013 and held it in 25 quarters.
- Oldfield Partners's Pfizer position peaked at $4.81M in Q3 2018.
- 2,323 funds tracked by Wall St. Rank held Pfizer as of Q3 2019.
Based on Oldfield Partners's 13F filing for Q3 2019, filed 22 Oct 2019.